NKTX

Nkarta, Inc.

• Dow Jones·03/31 13:33

  Nkarta Is Maintained at Outperform by Mizuho

• Dow Jones·03/31 13:33

  Nkarta Price Target Cut to $12.00/Share From $14.00 by Mizuho

• Benzinga·03/31 13:23

  Mizuho Maintains Outperform on Nkarta, Lowers Price Target to $12

• TipRanks·03/31 11:08

  Nkarta price target lowered to $12 from $14 at Mizuho

• TipRanks·03/28 05:20

  Analysts Are Bullish on Top Healthcare Stocks: Nkarta (NKTX), BioCardia (BCDA)

• TipRanks·03/28 05:00

  Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and Nkarta (NKTX)

• TipRanks·03/28 04:55

  Buy Rating Initiated on NKX019’s Differentiated CAR‑NK Platform and De‑Risked Autoimmune Opportunity Ahead of 2026 Proof‑of‑Concept Data

• TipRanks·03/26 13:20

  Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), QT Imaging Holdings (QTI) and Cardiff Oncology (CRDF)

• Dow Jones·03/26 12:31

  Nkarta Is Maintained at Buy by Needham

• Benzinga·03/26 12:21

  Needham Maintains Buy on Nkarta, Raises Price Target to $11

• TipRanks·03/26 11:51

  Nkarta price target raised to $11 from $10 at Needham

• TipRanks·03/26 10:41

  Nkarta Launches $100 Million At-the-Market Stock Offering

• Reuters·03/26 10:01

  Nkarta enters at-the-market equity distribution agreement; offering size grows to $100 million

• Seeking Alpha·03/26 07:41

  Nkarta files $350M shelf offering, plans $100M ATM stock sale via Stifel

• Benzinga·03/25 21:29

  Nkarta Files Base Prospectus To Offer Up To $350M In Securities